Merck has reached a deal to purchase ophthalmology brand Eyebiotech for $1.3 billion, according to a May 29 report from The Wall Street Journal.
Merck has reached a deal to purchase ophthalmology brand Eyebiotech for $1.3 billion, according to a May 29 report from The Wall Street Journal.